Simon Gollins

Professor Gollins qualified in Medicine at Oxford University, where he also carried out three years of laboratory-based research for a PhD. He later trained as a Clinical Oncologist at the Christie Hospital Manchester and Velindre Hospital, the South Wales regional cancer centre. He was the second consultant to work at the then new North Wales Cancer Treatment Centre (NWCTC) UK, from 1998, and has been Clinical Director of Oncology there since 2010. The NWCTC is a regional Cancer Centre delivering the full range of systemic therapy and chemotherapy to a population of approximately 750,000. He is Chair of the Colorectal Clinical Studies Group of the UK National Cancer Research Institute (NCRI), which has responsibility for the UK national colorectal trials portfolio. He is Honorary Professor at Bangor University School of Medical Sciences. His subspecialty clinical interestes include colorectal, upper GI, head and neck and urologcial cancer, delivering both sytemic and radiotherapy to his patients. He has wide clinical and translational research interests and is Chief Investigator of several UK national portfolio clinical trials, mainly within the field of neoadjuvant rectal cancer treatment. He is also Co-investigator of many trials in the field of colorectal and upper GI cancer. He is a named author on approximately 90 peer-reviewed publications, including Nature, New England Journal of Medicine, Lancet Oncology, Lancet Gastroenterology and Hepatology, and Journal of Clinical Oncology. He has also authored book chapters and many conference abstracts. His current main research focus is organ preservation in rectal cancer treatment.